X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (290) 290
Book / eBook (4) 4
Book Chapter (3) 3
Newspaper Article (3) 3
Book Review (2) 2
Patent (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (152) 152
life sciences & biomedicine (151) 151
humans (137) 137
cardiovascular system & cardiology (121) 121
cardiac & cardiovascular systems (115) 115
male (109) 109
female (106) 106
middle aged (95) 95
aged (90) 90
cardiovascular (76) 76
cardiology and cardiovascular medicine (65) 65
abridged index medicus (64) 64
risk factors (57) 57
treatment outcome (51) 51
diabetes (43) 43
internal medicine (43) 43
mortality (38) 38
time factors (38) 38
percutaneous coronary intervention (37) 37
heart attacks (36) 36
diabetes mellitus (32) 32
cardiology (31) 31
registries (31) 31
transluminal angioplasty (30) 30
cardiac patients (29) 29
prospective studies (29) 29
care and treatment (28) 28
risk assessment (26) 26
analysis (24) 24
angioplasty (24) 24
cardiovascular disease (24) 24
angioplasty, balloon, coronary - adverse effects (22) 22
coronary angiography (21) 21
follow-up studies (21) 21
myocardial infarction (21) 21
cardiovascular diseases (19) 19
coronary artery disease - therapy (18) 18
type 2 diabetes (18) 18
diabetics (17) 17
drug therapy (17) 17
retrospective studies (17) 17
ultrasonography, interventional (17) 17
united states (17) 17
united states - epidemiology (17) 17
coronary vessels (16) 16
endocrinology & metabolism (16) 16
hospital mortality (16) 16
incidence (16) 16
angioplasty, balloon, coronary (15) 15
diabetes mellitus, type 2 - drug therapy (15) 15
double-blind method (15) 15
hypoglycemic agents - therapeutic use (15) 15
peripheral vascular disease (15) 15
acute coronary syndromes (14) 14
coronary artery disease - mortality (14) 14
diabetes mellitus, type 2 - complications (14) 14
medical research (14) 14
multivariate analysis (14) 14
myocardial infarction - mortality (14) 14
patient outcomes (14) 14
platelet aggregation inhibitors - therapeutic use (14) 14
predictive value of tests (14) 14
prognosis (14) 14
stents (14) 14
atherosclerosis (13) 13
bleeding (13) 13
coronary artery bypass (13) 13
coronary artery disease - diagnostic imaging (13) 13
coronary heart disease (13) 13
drug-eluting stents (13) 13
general & internal medicine (13) 13
health aspects (13) 13
medicine, general & internal (13) 13
percutaneous coronary intervention - adverse effects (13) 13
angioplasty, balloon, coronary - mortality (12) 12
intravascular ultrasound (12) 12
patients (12) 12
severity of illness index (12) 12
acute coronary syndrome - therapy (11) 11
chronic disease (11) 11
heart attack (11) 11
heart failure (11) 11
medicine, experimental (11) 11
myocardial infarction - therapy (11) 11
studies (11) 11
aged, 80 and over (10) 10
chi-square distribution (10) 10
coronary occlusion - therapy (10) 10
hemorrhage (10) 10
insulin (10) 10
liraglutide (10) 10
veins & arteries (10) 10
acute coronary syndrome - diagnostic imaging (9) 9
adult (9) 9
coronary artery disease (9) 9
coronary vessels - diagnostic imaging (9) 9
disease progression (9) 9
health risk assessment (9) 9
myocardial infarction - epidemiology (9) 9
pci (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 07/2016, Volume 375, Issue 4, pp. 311 - 322
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
Medicine(all) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2011, Volume 364, Issue 3, pp. 226 - 235
In a prospective study, 697 patients with acute coronary syndromes underwent three-vessel coronary angiography and imaging after PCI. Of 132 subsequent major... 
intravascular ultrasound | major clinical study | coronary artery atherosclerosis | radiofrequency | heart infarction | unstable angina pectoris | percutaneous coronary intervention | acute coronary syndrome | angina pectoris | heart arrest | priority journal | female | human | atheroma | clinical trial | hospital readmission | aged | angiocardiography | recurrent disease | article | heart death | thin cap fibroatheroma | prospective study | adult | male | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Ultrasonography, Interventional - methods | Coronary Vessels - pathology | Prospective Studies | Patient Readmission | Humans | Middle Aged | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Disease Progression | Angioplasty, Balloon, Coronary | Coronary Artery Disease - diagnostic imaging | Coronary Angiography - methods | Coronary Artery Disease - complications | Acute Coronary Syndrome - etiology | Coronary Artery Disease - pathology | Acute Coronary Syndrome - therapy | Female | Aged | Usage | Care and treatment | Angiography | Atherosclerosis | Diagnosis | Cardiovascular diseases | Health aspects | Risk factors | Data collection | Cardiovascular disease | Heart attacks | Medical imaging | Angina pectoris | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2016, Volume 375, Issue 19, pp. 1834 - 1844
Journal Article
The American heart journal, ISSN 0002-8703, 04/2016, Volume 174, pp. 103 - 110
Exenatide once-weekly is an extended release formulation of exenatide, a glucagon-like peptide–1 receptor agonist, which can improve glycemic control, body... 
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Risk Assessment - methods | United States - epidemiology | Glucagon-Like Peptide 1 | Prognosis | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Peptides - administration & dosage | Incidence | Dose-Response Relationship, Drug | Microspheres | Hypoglycemic Agents - administration & dosage | Time Factors | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Venoms - administration & dosage | Adult | Female | Diabetes Mellitus, Type 2 - complications | Cardiovascular Diseases - etiology | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Factors | China - epidemiology | Diabetes Mellitus, Type 2 - blood | Ontario - epidemiology | Italy - epidemiology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Hypoglycemic agents | Glucagon | Cardiac patients | Heart attack | Corporate sponsorship | Heart attacks | Research & development--R&D | Pragmatism | Cardiovascular disease | Diabetes | Pharmaceutical industry | Patients | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article